Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 69 Colorectal Neoplasms 39 Rectal Neoplasms 33 Colonic Neoplasms 33 Central Nervous System Neoplasms 33 Glioblastoma 20 Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 17 Gliosarcoma 17 Stomach Neoplasms 15 Ovarian Neoplasms 14 Head and Neck Neoplasms 14 Pancreatic Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 11 Carcinoma, Ovarian Epithelial 11 Prostatic Neoplasms 10 Neoplasm Metastasis 10 Melanoma 10 Fallopian Tube Neoplasms 10 Esophageal Neoplasms 10 Carcinoma, Intraductal, Noninfiltrating 10 Astrocytoma 10 Uterine Cervical Neoplasms 9 Sarcoma 9 Brain Neoplasms 9 Liver Neoplasms 8 Kidney Neoplasms 8 Breast Neoplasms, Male 8 Breast Carcinoma In Situ 8 Salivary Gland Neoplasms 7

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06953882 2025-07-14

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡